Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 10, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptimmune Therapeutics Plc
| -47.70K |
$0.91 | -$43,446.98 | -38.86% | 75.06K |
Jul 10
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 5
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
|
Jul 3
| |||||||
Stoke Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Adaptimmune Therapeutics Plc
| 611.22K |
—
|
—
|
∞
| 611.22K |
Jun 1
| |||||||
Adaptimmune Therapeutics Plc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tcr2 Therapeutics Inc.
| -404.33K |
—
|
—
| -100.00% |
0
|
Jun 1
| |||||||
Black Diamond Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 15
| |||||||
Tcr2 Therapeutics Inc.
| -31.94K |
$1.10 | -$35,033.87 | -18.70% | 138.87K |
Dec 9 - Dec 13
|
Scheduled
| ||||||
Tcr2 Therapeutics Inc.
| -18.43K |
$1.27 | -$23,360.06 | -9.74% | 170.81K |
Dec 7 - Dec 8
|
Scheduled
| ||||||
Tcr2 Therapeutics Inc.
| -23.42K |
$1.36 | -$31,784.37 | -11.01% | 189.23K |
Dec 5 - Dec 6
|
Scheduled
| ||||||
Tcr2 Therapeutics Inc.
| 212.65K |
$1.39 | -$11,687.12 |
∞
| 212.65K |
Dec 1 - Dec 2
|
Scheduled
| ||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 17
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
| 265.46K |
Jul 5
| |||||||
Black Diamond Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Stoke Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 7
| |||||||
Tcr2 Therapeutics Inc.
| 1.43K |
$2.30 | $3,277.50 | +0.79% | 180.93K |
Feb 28
| |||||||
Tcr2 Therapeutics Inc.
| 175.42K |
$0.77 | $135,517.72 | +4,294.30% | 179.51K |
Aug 31 - Dec 10
| |||||||
Stoke Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Black Diamond Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Black Diamond Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 20
| |||||||
Tcr2 Therapeutics Inc.
| 1.82K |
$12.37 | $22,492.34 | +80.19% | 4.08K |
Aug 31 - Feb 28
| |||||||
Stoke Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 13
| |||||||
Stoke Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 10
| |||||||
Tcr2 Therapeutics Inc.
| 2.27K |
$11.25 | $25,493.70 |
∞
| 2.27K |
Aug 30 - Feb 28
| |||||||
Black Diamond Therapeutics, Inc.
| 51.83K |
—
|
—
|
∞
| 51.83K |
Feb 3
| |||||||
Black Diamond Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 19
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 11
| |||||||
Tcr2 Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Davita Healthcare Partners Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Davita Healthcare Partners Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Sep 9
| ||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 11
| ||||||
Regulus Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.